All Updates

All Updates

icon
Filter
Partnerships
Novartis and Abu Dhabi's Department of Health partner to advance genomics research and cancer therapy
Clinical Trial Technology
Jun 7, 2024
This week:
Funding
GrayMatter Robotics raises USD 45 million in Series B funding to accelerate AI-powered robotics solutions
Smart Factory
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Logistics Tech
Yesterday
Funding
Vecna Robotics raises USD 100 million in Series C funding; appoints new COO
Smart Factory
Yesterday
Funding
FairNow raises USD 3.5 million to advance AI governance solutions
Generative AI Infrastructure
Yesterday
Partnerships
Gravitics develops testing gauntlet for larger spacecraft in collaboration with NASA
Space Travel and Exploration Tech
Yesterday
M&A
knownwell acquires Alfie Health to integrate AI in primary and obesity care services
Telehealth
Yesterday
Funding
Pomelo Care raises USD 46 million in Series B funding to expand virtual maternal care
Telehealth
Yesterday
Funding
Isar Aerospace raises EUR 65 million, backed by NATO Innovation Fund
Space Travel and Exploration Tech
Yesterday
Product updates
Beyond Meat releases new Beyond Sausage, expanding its Beyond IV product line
Plant-based Meat
Yesterday
Product updates
Funding
SurrealDB raises USD 20 million in Series A; launches beta version of Surreal Cloud
Data Infrastructure & Analytics
Yesterday
Clinical Trial Technology

Clinical Trial Technology

Jun 7, 2024

Novartis and Abu Dhabi's Department of Health partner to advance genomics research and cancer therapy

Partnerships

  • The Department of Health in Abu Dhabi and global pharmaceutical provider Novartis have partnered to develop solutions in multiple medical fields, placing emphasis on advancing clinical genomics through the generation of real-world evidence and radioligand therapy for cancer patients.

  • The collaboration aims to elevate genomics research in cancer treatments, cardiovascular disease, and neuroscience and to enhance awareness and understanding of radioligand therapy, a precision-based treatment for advanced cancers.

  • The partnership will also support local and regional health needs, including the Emirati Genome Program, and will contribute to transforming the Health Technology Assessment.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.